Devendra Kumar Yadav
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Devendra Kumar Yadav has a total of 125 co-authors. Here are the top co-authors by number of shared publications:
- Prabudh Goel
Department of Paediatric Surgery, All India Institute of Medical Sciences, New Delhi, India
19 shared publications - Anjan Kumar Dhua
Department of Pediatric Surgery, All India Institute of Medical Sciences, New Delhi, India
18 shared publications - Vishesh Jain
Department of Paediatric Surgery, All India Institute of Medical Sciences, New Delhi, India
18 shared publications - Sandeep Agarwala
Department of Paediatric Surgery, All India Institute of Medical Sciences, New Delhi, India
12 shared publications - Minu Bajpai
Department of Pediatric Surgery, Yashoda Medicity, Indirapuram, Ghaziabad, India
9 shared publications - Sachit Anand
Department of Pediatric Surgery, All India Institute of Medical Sciences, New Delhi 110029, India
9 shared publications
Latest Publications
- 22 September 2026
- Published by Springer Nature in Pediatric Surgery International
- Vol. 42 (1) , 417
Semi-automated erythema quantification in infantile haemangioma receiving propranolol: a pilot feasibility study
Background Infantile haemangioma (IH) is the most common vascular tumour of infancy. Propranolol is first-line treatment, but response monitoring relies on subjective clinical assessment. Semi-automated photographic erythema quantification may offer a reproducible, low-cost adjunct monitoring tool. Objectives To develop a semi-automated Python-based erythema quantification tool for serial clinical photographs of IH, evaluate its feasibility and intra-rater reliability, and characterise the relationship between colour-based erythema change and clinician-assessed composite response. Methods Retrospective analysis of a prospective photographic registry at a tertiary paediatric surgery centre. Forty-nine infants with IH treated with propranolol were included. Serial clinical photographs (n = 251) were analysed using a custom Python tool. The erythema index (EI = [R − G] / [R + G + B]), a formula validated for quantification of cutaneous erythema from digital photographs, was calculated from manually selected lesion regions of interest (ROI). Intra-rater reliability was assessed by re-rating 22 photographs from five patients one week apart. Absolute EI change was correlated with prospectively recorded, blinded clinician response scores (0–10). Results Of 251 photographs, 242 (96.4%) were analysable (mean 4.9 visits per patient, range 2–11). Intra-rater reliability was high: ICC(A,1) = 0.990(95% CI 0.97–1.00); Bland–Altman mean difference − 0.005 EI units (95% limits of agreement − 0.023 to + 0.013). Mean baseline EI was 0.122 ± 0.058 and mean final EI was 0.115 ± 0.053. Absolute EI change did not correlate with clinician response scores (Pearson r = − 0.084, 95% CI − 0.357 to 0.202, p = 0.566; Spearman r = − 0.087, p = 0.554), consistent across three sensitivity analyses. Conclusions Semi-automated erythema quantification from clinical photographs of IH is feasible with high intra-rater reliability. These pilot findings should be interpreted as hypothesis-generating; the study is underpowered for definitive correlation testing, and prospective replication in an adequately powered cohort is required. In this pilot cohort, colour-based EI change alone was insufficient to track the clinician’s composite response assessment under real-world uncalibrated photography conditions, consistent with the partial-biomarker nature of colour-only analysis. Prospective studies with standardised photography incorporating colorimetric calibration and composite colour-plus-area scoring are warranted.
- 22 September 2026
- Published by Springer Nature in Pediatric Surgery International
- Vol. 42 (1) , 417
Semi-automated erythema quantification in infantile haemangioma receiving propranolol: a pilot feasibility study
Background Infantile haemangioma (IH) is the most common vascular tumour of infancy. Propranolol is first-line treatment, but response monitoring relies on subjective clinical assessment. Semi-automated photographic erythema quantification may offer a reproducible, low-cost adjunct monitoring tool. Objectives To develop a semi-automated Python-based erythema quantification tool for serial clinical photographs of IH, evaluate its feasibility and intra-rater reliability, and characterise the relationship between colour-based erythema change and clinician-assessed composite response. Methods Retrospective analysis of a prospective photographic registry at a tertiary paediatric surgery centre. Forty-nine infants with IH treated with propranolol were included. Serial clinical photographs (n = 251) were analysed using a custom Python tool. The erythema index (EI = [R − G] / [R + G + B]), a formula validated for quantification of cutaneous erythema from digital photographs, was calculated from manually selected lesion regions of interest (ROI). Intra-rater reliability was assessed by re-rating 22 photographs from five patients one week apart. Absolute EI change was correlated with prospectively recorded, blinded clinician response scores (0–10). Results Of 251 photographs, 242 (96.4%) were analysable (mean 4.9 visits per patient, range 2–11). Intra-rater reliability was high: ICC(A,1) = 0.990(95% CI 0.97–1.00); Bland–Altman mean difference − 0.005 EI units (95% limits of agreement − 0.023 to + 0.013). Mean baseline EI was 0.122 ± 0.058 and mean final EI was 0.115 ± 0.053. Absolute EI change did not correlate with clinician response scores (Pearson r = − 0.084, 95% CI − 0.357 to 0.202, p = 0.566; Spearman r = − 0.087, p = 0.554), consistent across three sensitivity analyses. Conclusions Semi-automated erythema quantification from clinical photographs of IH is feasible with high intra-rater reliability. These pilot findings should be interpreted as hypothesis-generating; the study is underpowered for definitive correlation testing, and prospective replication in an adequately powered cohort is required. In this pilot cohort, colour-based EI change alone was insufficient to track the clinician’s composite response assessment under real-world uncalibrated photography conditions, consistent with the partial-biomarker nature of colour-only analysis. Prospective studies with standardised photography incorporating colorimetric calibration and composite colour-plus-area scoring are warranted.
- Open Access
- 17 July 2026
- Published by Georg Thieme Verlag KG in Indian Journal of Plastic Surgery
Oral Propranolol Therapy for Parotid Infantile Hemangiomas: Lesion Characteristics Affecting Outcome
Parotid hemangioma is a common type of infantile hemangioma (IH) in the head and neck region. Oral propranolol therapy has been therapeutic for head and neck IH. The objective was to investigate the varied characteristics of lesions and the types of response to propranolol therapy in the treatment of parotid IHs from July 2013 to November 2024. After an initial screening and investigations (random blood sugar, renal and liver function tests), counselling, and consent, 3 mg/kg/d of propranolol was started. Children were evaluated after 2 weeks, 1 month, 2 months, and at 3 months after the start of treatment by photographic assessment. Response was noted in terms of percentage reduction and charted against various lesion characteristics. Statistical analysis was conducted to determine the effectiveness of propranolol with regard to different lesion characteristics, namely site, size, associated skin discoloration, extension, and consistency. Out of total 12 patients, nine were males. Nine had right-sided lesions. One had an ulcerated lesion, two were deep, rest superficial as well as deep. Six patients showed more than 50% reduction of lesion, four showed >90% reduction to complete disappearance, one patient had <50% reduction and one had no response at all. Only one patient had re-growth after 4 months of discontinuation of treatment and was restarted on propranolol. Propranolol pharmacotherapy alone was more effective in reducing the size of infantile parotid IH that were superficial, firm, and smaller in size, as compared to those that were deep lesions and flabby to feel.
- 17 July 2026
- Published by Georg Thieme Verlag KG in Indian Journal of Plastic Surgery
Open AccessOral Propranolol Therapy for Parotid Infantile Hemangiomas: Lesion Characteristics Affecting Outcome
Parotid hemangioma is a common type of infantile hemangioma (IH) in the head and neck region. Oral propranolol therapy has been therapeutic for head and neck IH. The objective was to investigate the varied characteristics of lesions and the types of response to propranolol therapy in the treatment of parotid IHs from July 2013 to November 2024. After an initial screening and investigations (random blood sugar, renal and liver function tests), counselling, and consent, 3 mg/kg/d of propranolol was started. Children were evaluated after 2 weeks, 1 month, 2 months, and at 3 months after the start of treatment by photographic assessment. Response was noted in terms of percentage reduction and charted against various lesion characteristics. Statistical analysis was conducted to determine the effectiveness of propranolol with regard to different lesion characteristics, namely site, size, associated skin discoloration, extension, and consistency. Out of total 12 patients, nine were males. Nine had right-sided lesions. One had an ulcerated lesion, two were deep, rest superficial as well as deep. Six patients showed more than 50% reduction of lesion, four showed >90% reduction to complete disappearance, one patient had <50% reduction and one had no response at all. Only one patient had re-growth after 4 months of discontinuation of treatment and was restarted on propranolol. Propranolol pharmacotherapy alone was more effective in reducing the size of infantile parotid IH that were superficial, firm, and smaller in size, as compared to those that were deep lesions and flabby to feel.
- 3 June 2026
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 22 (5) , 106058
Stretched penile length in boys with hypospadias: Population-based analysis using validated nomogram
- 3 June 2026
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 22 (5) , 106058
Stretched penile length in boys with hypospadias: Population-based analysis using validated nomogram
- 1 April 2026
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 22 (4) , 105911
Quality of life in hypospadias: Systematic review of HRQoL-based analyses
- 1 April 2026
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 22 (4) , 105911
Quality of life in hypospadias: Systematic review of HRQoL-based analyses
- 13 March 2026
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 22 (4) , 105880
FREM2 as a candidate gene for posterior urethral valves: Evidence from a case-parent cohort
- 13 March 2026
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 22 (4) , 105880
FREM2 as a candidate gene for posterior urethral valves: Evidence from a case-parent cohort
- 7 November 2025
- Published by Springer Nature in Pediatric Surgery International
- Vol. 42 (1) , 1-13
Prenatal imaging for hypospadias: a bayesian analysis-based systematic review of diagnostic accuracy and key imaging features
Background The antenatal diagnosis of hypospadias has implications for parental counselling, decision-making and organizing postnatal management. Recent imaging advancements have enabled antenatal detection of hypospadias with significant implications for parental psychology and clinical management. However, there is considerable variability in the application of the diagnostic techniques and their reliability or diagnostic accuracy. Objective To assess the diagnostic accuracy of prenatal imaging modalities in the antenatal detection of hypospadias using a Bayesian statistical framework and to identify key imaging features that enhance prenatal diagnosis. Materials and methods Comprehensive searches across PubMed, Scopus and Google Scholar identified primary research on antenatal hypospadias diagnosis, which was subject to systematic review as per PRISMA guidelines. A Bayesian model employing non-informative priors (Beta (1,1)) was used to calculate pooled sensitivity and specificity, along with corresponding 95% credible intervals, enabling the probabilistic quantification of diagnostic uncertainty. Results The review included 34 studies published between 1989 and 2023, representing 280 pregnant females with 282 foetuses. Bayesian analysis revealed high sensitivity (0.87; 95% CrI: 0.80–0.92) and moderate specificity (0.46; 95% CrI: 0.34–0.58), translating into reliable detection of cases, though with a higher risk of false positives. While 2D sonography served as the universal screening tool (100%), supplementary techniques included 3D sonography (32.3%), color Doppler (32.3%) and magnetic resonance imaging (8.8%). Diagnosis occurred at a mean gestational age of 26.3 ± 5.5 weeks (range 20–39 weeks). Key imaging features identified were ventral curvature (n = 62), a shortened penile shaft (n = 52), a blunt penile tip (n = 60), Meizner’s tulip sign (n = 51) and a bifid scrotum (n = 20). The tulip sign, bifid scrotum and cranially-directed phallus were exclusively associated with proximal variants. Conclusions While 2D-ultrasonography remains the primary investigative modality, antenatal detection of hypospadias may be improved through the integration of 3D ultrasound, Doppler and MRI, particularly in complex cases. Confirmatory postnatal evaluation is crucial to address the moderate specificity and risk of false-positive results. However, there is a need to address the disparities in access to advanced imaging and technical expertise in prenatal diagnosis.
- 7 November 2025
- Published by Springer Nature in Pediatric Surgery International
- Vol. 42 (1) , 1-13
Prenatal imaging for hypospadias: a bayesian analysis-based systematic review of diagnostic accuracy and key imaging features
Background The antenatal diagnosis of hypospadias has implications for parental counselling, decision-making and organizing postnatal management. Recent imaging advancements have enabled antenatal detection of hypospadias with significant implications for parental psychology and clinical management. However, there is considerable variability in the application of the diagnostic techniques and their reliability or diagnostic accuracy. Objective To assess the diagnostic accuracy of prenatal imaging modalities in the antenatal detection of hypospadias using a Bayesian statistical framework and to identify key imaging features that enhance prenatal diagnosis. Materials and methods Comprehensive searches across PubMed, Scopus and Google Scholar identified primary research on antenatal hypospadias diagnosis, which was subject to systematic review as per PRISMA guidelines. A Bayesian model employing non-informative priors (Beta (1,1)) was used to calculate pooled sensitivity and specificity, along with corresponding 95% credible intervals, enabling the probabilistic quantification of diagnostic uncertainty. Results The review included 34 studies published between 1989 and 2023, representing 280 pregnant females with 282 foetuses. Bayesian analysis revealed high sensitivity (0.87; 95% CrI: 0.80–0.92) and moderate specificity (0.46; 95% CrI: 0.34–0.58), translating into reliable detection of cases, though with a higher risk of false positives. While 2D sonography served as the universal screening tool (100%), supplementary techniques included 3D sonography (32.3%), color Doppler (32.3%) and magnetic resonance imaging (8.8%). Diagnosis occurred at a mean gestational age of 26.3 ± 5.5 weeks (range 20–39 weeks). Key imaging features identified were ventral curvature (n = 62), a shortened penile shaft (n = 52), a blunt penile tip (n = 60), Meizner’s tulip sign (n = 51) and a bifid scrotum (n = 20). The tulip sign, bifid scrotum and cranially-directed phallus were exclusively associated with proximal variants. Conclusions While 2D-ultrasonography remains the primary investigative modality, antenatal detection of hypospadias may be improved through the integration of 3D ultrasound, Doppler and MRI, particularly in complex cases. Confirmatory postnatal evaluation is crucial to address the moderate specificity and risk of false-positive results. However, there is a need to address the disparities in access to advanced imaging and technical expertise in prenatal diagnosis.
- 24 August 2025
- Published by Springer Nature in Pediatric Surgery International
- Vol. 41 (1) , 1-8
Serum matrix metalloproteinase-7 (MMP-7) as a Biomarker for differentiating biliary atresia from neonatal hepatitis: evidence synthesis through systematic review and meta-analysis
Purpose Biliary atresia (BA) requires timely differentiation from neonatal hepatitis (NH) and early surgery for optimal outcomes. This systematic review and meta-analysis evaluated the diagnostic performance of serum Matrix metalloproteinase-7 (MMP-7) as a biomarker for differentiating BA from NH. Methods The PRISMA-DTA compliant synthesis was based upon primary data available till date, assessing the role of MMP-7 in diagnosing BA. Studies reporting diagnostic accuracy metrics were included. Pooled sensitivity, specificity, likelihood ratios, diagnostic odds ratio (DOR) and area under the summary receiver operating characteristic (SROC) curve were calculated. Results Twenty-four studies (7298 participants: 3301 BA, 2,930 NH and 1067 controls) were analysed. The serum MMP-7 values ranged from 1.2 to 10.3 ng/mL in controls, 1.88–12.57 ng/mL in NH and 10.26–121.1 ng/mL in BA, with interquartile ranges spanning 1.08–25.3, 0.78–34.0 and 3.38–368.0 ng/mL, respectively. Median serum MMP-7 levels were consistently higher in BA vis-a-vis NH and the control population. Pooled sensitivity and specificity of MMP-7 as a diagnostic biomarker were 0.94 and 0.88, respectively. The DOR was 120.09 and the SROC AUC was 0.967. Conclusion Serum MMP-7 demonstrates excellent diagnostic accuracy for differentiating BA from NH. Further research should focus on assay standardization and age-specific reference ranges to optimize clinical utility.
- 24 August 2025
- Published by Springer Nature in Pediatric Surgery International
- Vol. 41 (1) , 1-8
Serum matrix metalloproteinase-7 (MMP-7) as a Biomarker for differentiating biliary atresia from neonatal hepatitis: evidence synthesis through systematic review and meta-analysis
Purpose Biliary atresia (BA) requires timely differentiation from neonatal hepatitis (NH) and early surgery for optimal outcomes. This systematic review and meta-analysis evaluated the diagnostic performance of serum Matrix metalloproteinase-7 (MMP-7) as a biomarker for differentiating BA from NH. Methods The PRISMA-DTA compliant synthesis was based upon primary data available till date, assessing the role of MMP-7 in diagnosing BA. Studies reporting diagnostic accuracy metrics were included. Pooled sensitivity, specificity, likelihood ratios, diagnostic odds ratio (DOR) and area under the summary receiver operating characteristic (SROC) curve were calculated. Results Twenty-four studies (7298 participants: 3301 BA, 2,930 NH and 1067 controls) were analysed. The serum MMP-7 values ranged from 1.2 to 10.3 ng/mL in controls, 1.88–12.57 ng/mL in NH and 10.26–121.1 ng/mL in BA, with interquartile ranges spanning 1.08–25.3, 0.78–34.0 and 3.38–368.0 ng/mL, respectively. Median serum MMP-7 levels were consistently higher in BA vis-a-vis NH and the control population. Pooled sensitivity and specificity of MMP-7 as a diagnostic biomarker were 0.94 and 0.88, respectively. The DOR was 120.09 and the SROC AUC was 0.967. Conclusion Serum MMP-7 demonstrates excellent diagnostic accuracy for differentiating BA from NH. Further research should focus on assay standardization and age-specific reference ranges to optimize clinical utility.
- 26 July 2025
- Published by Springer Nature in Pediatric Surgery International
- Vol. 41 (1) , 1-12
Novel CTNNB1 gene mutations reveal critical pathogenic mechanisms in pediatric hepatoblastoma
Background Hepatoblastoma (HB) is the most common primary malignant liver tumor in children, with alterations in the Wnt/β-catenin signaling pathway implicated in up to 90% of cases. The CTNNB1, which codes for β-catenin protein, plays a crucial role in this pathway, but its mutation landscape across diverse populations requires further investigation. Objectives To analyse and characterize the genetic variations in the CTNNB1 across three geographically diverse cohorts of hepatoblastoma patients and understand their potential pathogenic mechanisms. Methods The exome data for 54 hepatoblastoma tissue samples was subjected to quality control and alignment to GRCh38. SNVs were identified using GATK/Mutect2 and annotated using multiple databases. CTNNB1 gene variants were filtered and analyzed using cBioPortal, CONSURF 3.0, STRING database, and VarElect for comprehensive molecular and phenotypic analysis. Results CTNNB1 mutations were identified in 88.9% of patients, with 21 unique variants found in 24 patients post-filtering. Exon 3 was most frequently affected, with 17 unique mutations present in 91.66% of mutation-positive patients. The most common variants were c.101G > T (p.Gly34Val), c.98C > T (p.Ser33Phe), and c.98C > A (p.Ser33Tyr). Novel mutations were identified at positions S29 and I35, while additional variations were found in exons 4, 7, 10, and 13. Conclusion This study identified significant CTNNB1 genetic variations in hepatoblastoma, confirming exon 3 as a critical mutational hotspot. The findings enhance our understanding of HB pathogenesis and suggest potential therapeutic targets, particularly in the Wnt/β-catenin signaling pathway. These mutations may serve as valuable diagnostic and prognostic biomarkers for personalized treatment approaches in pediatric hepatoblastoma.
- 26 July 2025
- Published by Springer Nature in Pediatric Surgery International
- Vol. 41 (1) , 1-12
Novel CTNNB1 gene mutations reveal critical pathogenic mechanisms in pediatric hepatoblastoma
Background Hepatoblastoma (HB) is the most common primary malignant liver tumor in children, with alterations in the Wnt/β-catenin signaling pathway implicated in up to 90% of cases. The CTNNB1, which codes for β-catenin protein, plays a crucial role in this pathway, but its mutation landscape across diverse populations requires further investigation. Objectives To analyse and characterize the genetic variations in the CTNNB1 across three geographically diverse cohorts of hepatoblastoma patients and understand their potential pathogenic mechanisms. Methods The exome data for 54 hepatoblastoma tissue samples was subjected to quality control and alignment to GRCh38. SNVs were identified using GATK/Mutect2 and annotated using multiple databases. CTNNB1 gene variants were filtered and analyzed using cBioPortal, CONSURF 3.0, STRING database, and VarElect for comprehensive molecular and phenotypic analysis. Results CTNNB1 mutations were identified in 88.9% of patients, with 21 unique variants found in 24 patients post-filtering. Exon 3 was most frequently affected, with 17 unique mutations present in 91.66% of mutation-positive patients. The most common variants were c.101G > T (p.Gly34Val), c.98C > T (p.Ser33Phe), and c.98C > A (p.Ser33Tyr). Novel mutations were identified at positions S29 and I35, while additional variations were found in exons 4, 7, 10, and 13. Conclusion This study identified significant CTNNB1 genetic variations in hepatoblastoma, confirming exon 3 as a critical mutational hotspot. The findings enhance our understanding of HB pathogenesis and suggest potential therapeutic targets, particularly in the Wnt/β-catenin signaling pathway. These mutations may serve as valuable diagnostic and prognostic biomarkers for personalized treatment approaches in pediatric hepatoblastoma.